ARQT ARCUTIS BIOTHERAPEUTICS
Health Care · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about ARCUTIS BIOTHERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
11 rated views · 12 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8077
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8066
Recent analyst activity · last 90 days
Our tracked history has 6 reports on ARQT from 5 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Cowen raised its target from $35.00 (set 26 Feb 2026) to $40.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Steve Seedhouse | Buy | 15 Oct 2026 | 48.00 USD |
| Goldman Sachs | Richard Law | Hold | 25 Jun 2026 | 35.00 USD |
| Guggenheim | Seamus Fernandez | Buy | 19 Oct 2026 | 44.00 USD |
| H.C. Wainwright | Douglas Tsao | Buy | 6 Aug 2026 | 34.00 USD |
| Jefferies | Andrew Tsai | Buy | 8 Oct 2026 | 39.00 USD |
| Jefferies | Kambiz Yazdi | Buy | 8 Oct 2026 | 39.00 USD |
| Mizuho | Uy Ear | Buy | 2 Mar 2026 | 35.00 USD |
| Morgan Stanley | Vikram Purohit | Buy | 6 Aug 2026 | 38.00 USD |
| Needham | Serge Belanger | Buy | 6 Aug 2026 | 40.00 USD |
| TD Cowen | Tyler Van Buren | Buy | 26 Feb 2026 | 35.00 USD |
| Weiss Ratings | Unnamed analyst | — | 29 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:18 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.